{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:20:05Z","timestamp":1792059605100,"version":"4.4.0"},"reference-count":33,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,9,11]]},"abstract":"<jats:title>Key Points<\/jats:title><jats:p>Co-HP binds to CLEC-2 at N120 and K211, novel binding sites for podoplanin, and inhibits their interaction. Co-HP prevents hematogenous tumor metastasis and arterial\/venous thrombosis in mice, without a significant increase in bleeding time.<\/jats:p>","DOI":"10.1182\/bloodadvances.2018016261","type":"journal-article","created":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T15:54:54Z","timestamp":1536249294000},"page":"2214-2225","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":68,"title":["Cobalt hematoporphyrin inhibits CLEC-2\u2013podoplanin interaction, tumor metastasis, and arterial\/venous thrombosis in mice"],"prefix":"10.1182","volume":"2","author":[{"given":"Nagaharu","family":"Tsukiji","sequence":"first","affiliation":[{"name":"Department of Clinical and Laboratory Medicine, Faculty of Medicine, University of Yamanashi, Chuo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Osada","sequence":"additional","affiliation":[{"name":"Department of Clinical and Laboratory Medicine, Faculty of Medicine, University of Yamanashi, Chuo, Japan;"},{"name":"School of Medical Technology, Faculty of Health Science, Gumma Paz University, Takasaki, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Clinical and Laboratory Medicine, Faculty of Medicine, University of Yamanashi, Chuo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Shirai","sequence":"additional","affiliation":[{"name":"Department of Clinical and Laboratory Medicine, Faculty of Medicine, University of Yamanashi, Chuo, Japan;"},{"name":"Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaneo","family":"Satoh","sequence":"additional","affiliation":[{"name":"Department of Clinical and Laboratory Medicine, Faculty of Medicine, University of Yamanashi, Chuo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Inoue","sequence":"additional","affiliation":[{"name":"Infection Control Unit, University of Yamanashi Hospital, Chuo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiko","family":"Umetani","sequence":"additional","affiliation":[{"name":"Department of Clinical and Laboratory Medicine, Faculty of Medicine, University of Yamanashi, Chuo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihiro","family":"Mochizuki","sequence":"additional","affiliation":[{"name":"Faculty of Life and Environmental Science, University of Yamanashi, Kofu, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamio","family":"Saito","sequence":"additional","affiliation":[{"name":"Collaboration Promotion Unit, Global Research Cluster, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichi","family":"Kojima","sequence":"additional","affiliation":[{"name":"Liver Cancer Prevention Research Unit, Center for Integrative Medical Sciences, RIKEN, Wako, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9864-8371","authenticated-orcid":false,"given":"Hideyuki","family":"Shinmori","sequence":"additional","affiliation":[{"name":"Faculty of Life and Environmental Science, University of Yamanashi, Kofu, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Ozaki","sequence":"additional","affiliation":[{"name":"Fuefuki Chuo Hospital, Fuefuki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsue","family":"Suzuki-Inoue","sequence":"additional","affiliation":[{"name":"Department of Clinical and Laboratory Medicine, Faculty of Medicine, University of Yamanashi, Chuo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2018,9,6]]},"reference":[{"issue":"6","key":"2019111615595435800_B1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2183\/pjab.84.189","article-title":"Platelet aggregation in the formation of tumor metastasis","volume":"84","author":"Tsuruo","year":"2008","journal-title":"Proc Jpn Acad, Ser B, Phys Biol Sci"},{"issue":"5B","key":"2019111615595435800_B2","first-page":"2997","article-title":"The role of podoplanin in tumor progression and metastasis","volume":"28","author":"Raica","year":"2008","journal-title":"Anticancer Res"},{"issue":"7","key":"2019111615595435800_B3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/cup.12322","article-title":"Podoplanin expression in cancer-associated fibroblasts predicts aggressive behavior in melanoma","volume":"41","author":"Kan","year":"2014","journal-title":"J Cutan Pathol"},{"issue":"5","key":"2019111615595435800_B4","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00401-006-0063-y","article-title":"Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression","volume":"111","author":"Mishima","year":"2006","journal-title":"Acta Neuropathol"},{"issue":"2","key":"2019111615595435800_B5","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood-2005-05-1994","article-title":"A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2","volume":"107","author":"Suzuki-Inoue","year":"2006","journal-title":"Blood"},{"issue":"36","key":"2019111615595435800_B6","doi-asserted-by":"crossref","first-page":"25993","DOI":"10.1074\/jbc.M702327200","article-title":"Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells","volume":"282","author":"Suzuki-Inoue","year":"2007","journal-title":"J Biol Chem"},{"issue":"suppl 2","key":"2019111615595435800_B7","first-page":"226","article-title":"CLEC-2 facilitates hematogenous tumor metastasis and in vitro tumor growth, but not in vivo tumor growth","volume":"13","author":"Shirai","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2019111615595435800_B8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1349-7006.2007.00634.x","article-title":"Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2","volume":"99","author":"Kato","year":"2008","journal-title":"Cancer Sci"},{"issue":"2","key":"2019111615595435800_B9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2002-12-3882","article-title":"Platelet-collagen interaction: is GPVI the central receptor?","volume":"102","author":"Nieswandt","year":"2003","journal-title":"Blood"},{"issue":"9","key":"2019111615595435800_B10","doi-asserted-by":"crossref","first-page":"e0139357","DOI":"10.1371\/journal.pone.0139357","article-title":"Vascular smooth muscle cells stimulate platelets and facilitate thrombus formation through platelet CLEC-2: implications in atherothrombosis","volume":"10","author":"Inoue","year":"2015","journal-title":"PLoS One"},{"issue":"32","key":"2019111615595435800_B11","doi-asserted-by":"crossref","first-page":"24494","DOI":"10.1074\/jbc.M110.130575","article-title":"Essential in vivo roles of the C-type lectin receptor CLEC-2: embryonic\/neonatal lethality of CLEC-2-deficient mice by blood\/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets","volume":"285","author":"Suzuki-Inoue","year":"2010","journal-title":"J Biol Chem"},{"issue":"16","key":"2019111615595435800_B12","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1182\/blood-2009-05-222273","article-title":"CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis","volume":"114","author":"May","year":"2009","journal-title":"Blood"},{"issue":"5","key":"2019111615595435800_B13","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/ATVBAHA.112.300672","article-title":"Combined in vivo depletion of glycoprotein VI and C-type lectin-like receptor 2 severely compromises hemostasis and abrogates arterial thrombosis in mice","volume":"33","author":"Bender","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"14","key":"2019111615595435800_B14","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1182\/blood-2016-09-742999","article-title":"Mice with a deficiency in CLEC-2 are protected against deep vein thrombosis","volume":"129","author":"Payne","year":"2017","journal-title":"Blood"},{"issue":"18","key":"2019111615595435800_B15","doi-asserted-by":"crossref","first-page":"8951","DOI":"10.1128\/JVI.00136-06","article-title":"DC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by platelets","volume":"80","author":"Chaipan","year":"2006","journal-title":"J Virol"},{"issue":"7","key":"2019111615595435800_B16","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nbt.1644","article-title":"A mouse knockout library for secreted and transmembrane proteins","volume":"28","author":"Tang","year":"2010","journal-title":"Nat Biotechnol"},{"issue":"12","key":"2019111615595435800_B17","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1084\/jem.20150057","article-title":"CLEC-2 in megakaryocytes is critical for maintenance of hematopoietic stem cells in the bone marrow [published correction appears in J Exp Med. 2015;212(13):2323]","volume":"212","author":"Nakamura-Ishizu","year":"2015","journal-title":"J Exp Med"},{"issue":"13","key":"2019111615595435800_B18","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1182\/blood-2015-08-663708","article-title":"Podoplanin-positive periarteriolar stromal cells promote megakaryocyte growth and proplatelet formation in mice by CLEC-2","volume":"127","author":"Tamura","year":"2016","journal-title":"Blood"},{"issue":"2","key":"2019111615595435800_B19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/jth.13590","article-title":"Physiologic and pathophysiologic roles of interaction between C-type lectin-like receptor 2 and podoplanin: partners from in utero to adulthood","volume":"15","author":"Suzuki-Inoue","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2019111615595435800_B20","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1006\/bbrc.1998.8516","article-title":"Rhodocytin, a functional novel platelet agonist belonging to the heterodimeric C-type lectin family, induces platelet aggregation independently of glycoprotein Ib","volume":"245","author":"Shin","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"2019111615595435800_B21","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/jth.13604","article-title":"C-type lectin-like receptor 2 promotes hematogenous tumor metastasis and prothrombotic state in tumor-bearing mice","volume":"15","author":"Shirai","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"16","key":"2019111615595435800_B22","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J Comput Chem"},{"issue":"5","key":"2019111615595435800_B23","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10822-010-9352-6","article-title":"Ligand docking and binding site analysis with PyMOL and Autodock\/Vina","volume":"24","author":"Seeliger","year":"2010","journal-title":"J Comput Aided Mol Des"},{"issue":"12","key":"2019111615595435800_B24","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.str.2014.09.009","article-title":"A platform of C-type lectin-like receptor CLEC-2 for binding O-glycosylated podoplanin and nonglycosylated rhodocytin","volume":"22","author":"Nagae","year":"2014","journal-title":"Structure"},{"issue":"2","key":"2019111615595435800_B25","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1074\/jbc.M006191200","article-title":"Rhodocytin induces platelet aggregation by interacting with glycoprotein Ia\/IIa (GPIa\/IIa, Integrin alpha 2beta 1). Involvement of GPIa\/IIa-associated src and protein tyrosine phosphorylation","volume":"276","author":"Suzuki-Inoue","year":"2001","journal-title":"J Biol Chem"},{"issue":"24","key":"2019111615595435800_B26","doi-asserted-by":"crossref","first-page":"20882","DOI":"10.1074\/jbc.M101585200","article-title":"Aggretin, a heterodimeric C-type lectin from Calloselasma rhodostoma (Malayan pit viper), stimulates platelets by binding to \u03b12\u03b21 integrin and glycoprotein Ib, activating Syk and phospholipase C\u03b3 2, but does not involve the glycoprotein VI\/Fc receptor \u03b3 chain collagen receptor","volume":"276","author":"Navdaev","year":"2001","journal-title":"J Biol Chem"},{"issue":"40","key":"2019111615595435800_B27","doi-asserted-by":"crossref","first-page":"42733","DOI":"10.18632\/oncotarget.5811","article-title":"Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasis","volume":"6","author":"Chang","year":"2015","journal-title":"Oncotarget"},{"issue":"51","key":"2019111615595435800_B28","doi-asserted-by":"crossref","first-page":"51599","DOI":"10.1074\/jbc.M309935200","article-title":"Molecular identification of Aggrus\/T1alpha as a platelet aggregation-inducing factor expressed in colorectal tumors","volume":"278","author":"Kato","year":"2003","journal-title":"J Biol Chem"},{"issue":"2","key":"2019111615595435800_B29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10555-017-9672-2","article-title":"Platelet-activating factor podoplanin: from discovery to drug development","volume":"36","author":"Takemoto","year":"2017","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"2019111615595435800_B30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1042\/BJ20071216","article-title":"Renal cells activate the platelet receptor CLEC-2 through podoplanin","volume":"411","author":"Christou","year":"2008","journal-title":"Biochem J"},{"issue":"9","key":"2019111615595435800_B31","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1110\/ps.035568.108","article-title":"Crystal structure of rhodocytin, a ligand for the platelet-activating receptor CLEC-2","volume":"17","author":"Watson","year":"2008","journal-title":"Protein Sci"},{"issue":"5-6","key":"2019111615595435800_B32","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10719-012-9415-0","article-title":"Structural and functional conservation of CLEC-2 with the species-specific regulation of transcript expression in evolution","volume":"29","author":"Wang","year":"2012","journal-title":"Glycoconj J"},{"issue":"20","key":"2019111615595435800_B33","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1182\/blood-2017-03-771907","article-title":"CLEC-2 contributes to hemostasis independently of classical hemITAM signaling in mice","volume":"130","author":"Haining","year":"2017","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/17\/2214\/881645\/advances016261.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/17\/2214\/881645\/advances016261.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T01:08:39Z","timestamp":1720573719000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/2\/17\/2214\/15852\/Cobalt-hematoporphyrin-inhibits-CLEC2podoplanin"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,6]]},"references-count":33,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2018,9,11]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2018016261","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,6]]}}}